Pretomanid Completed Phase 3 Trials for Tuberculosis, Pulmonary, Drug Sensitive / Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) Treatment

Indications	Status	Purpose	Phase
DBCOND0074117 (Tuberculosis, Pulmonary, Drug Sensitive) DBCOND0072806 (Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB))	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT02342886	Shortening Treatment by Advancing Novel Drugs	Ethambutol (DB00330) Isoniazid (DB00951) Moxifloxacin (DB00218) Pretomanid (DB05154) Pyrazinamide (DB00339) Rifampin (DB01045)